Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino.

Authors:
Shantanu Karkare Deepak Bhatnagar

Appl Microbiol Biotechnol 2006 Aug 9;71(5):575-86. Epub 2006 May 9.

Apticraft Systems (P) Ltd. 142, Electronics Complex, Indore, 452010, India.

Nucleic acid analogs and mimics are commonly the modifications of native nucleic acids at the nucleobase, the sugar ring, or the phosphodiester backbone. Many forms of promising nucleic acid analogs and mimics are available, such as locked nucleic acids (LNAs), peptide nucleic acids (PNAs), and morpholinos. LNAs, PNAs, and morpholinos can form both duplexes and triplexes and have improved biostability. They have become a general and versatile tool for DNA and RNA recognition. LNA is a general and versatile tool for specific, high-affinity recognition of single-stranded DNA (ssDNA) and single-stranded RNA (ssRNA). LNA can be used for designing LNA oligoes for hybridization studies or as real time polymerase chain reaction probes in the form of Taqman probes. LNA also has therapeutic and diagnostic applications. PNA is another type of DNA analog with neutral charge. The extreme stability of PNA makes it an ideal candidate for the antisense and antigene application. PNA is used as probe for gene cloning, mutation detection, and in homologous recombination studies. It was also used to design transcription factor decoy molecules for target gene induction. Morpholino, another structural type, was devised to circumvent cost problems associated with DNA analogs. It has become the premier knockdown tool in developmental biology due to its cytosolic delivery in the embryos by microinjection. Thus, the nucleic acid analogs provide an advantage to design and implementation, therapies, and research assays, which were not implemented due to limitations associated with standard nucleic acids chemistry.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00253-006-0434-2DOI Listing
August 2006

Publication Analysis

Top Keywords

acid analogs
16
nucleic acid
16
nucleic acids
16
analogs mimics
12
applications pna
8
versatile tool
8
pnas morpholinos
8
promising nucleic
8
general versatile
8
nucleic
7
lna
5
analogs
5
stability pna
4
pna ideal
4
charge extreme
4
dna analog
4
analog neutral
4
neutral charge
4
extreme stability
4
antigene application
4

Altmetric Statistics


Show full details
18 Total Shares
18 Citations

Similar Publications

Biosynthesis, total synthesis, and biological profiles of Ergot alkaloids.

Authors:
Nikhil R Tasker Peter Wipf

Alkaloids Chem Biol 2021 30;85:1-112. Epub 2020 Sep 30.

Department of Chemistry, University of Pittsburgh, Pittsburgh, PA, United States. Electronic address:

While the use of ergot alkaloids in folk medicine has been practiced for millennia, systematic investigations on their therapeutic potential began about 100 years ago. Subsequently, Albert Hofmann's discovery of lysergic acid diethylamide (LSD) and its intense psychedelic properties garnered worldwide attention and prompted further studies of this compound class. As a result, several natural ergot alkaloids were discovered and unnatural analogs were synthesized, and some were used to treat an array of maladies, including Alzheimer's and Parkinson's disease. Read More

View Article and Full-Text PDF
September 2020
Similar Publications

A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.

Authors:
Yash Pal Singh Himanshu Rai Gourav Singh Gireesh Kumar Singh Sunil Mishra Saroj Kumar S Srikrishna Gyan Modi

Eur J Med Chem 2021 Feb 15;215:113278. Epub 2021 Feb 15.

Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, 221005, India. Electronic address:

Alzheimer's disease (AD) is an age-related multifactorial neurodegenerative disorder characterized by severe central cholinergic neuronal loss, gradually contributing to cognitive dysfunction and impaired motor activity, resulting in the brain's cell death at the later stages of AD. Although the etiology of AD is not well understood, however, several factors such as oxidative stress, deposition of amyloid-β (Aβ) peptides to form Aβ plaques, intraneuronal accumulation of hyperphosphorylated tau protein, and low level of acetylcholine are thought to play a major role in the pathogenesis of AD. There is practically no drug for AD treatment that can address the basic factors responsible for the neurodegeneration and slow down the disease progression. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Discovery ofCYR715:Anovel carboxylic acid-containing soluble guanylate cyclase stimulator.

Authors:
Glen R Rennie Timothy C Barden Sylvie G Bernier Andrew Carvalho Renee Deming Peter Germano Colleen Hudson G-Yoon J Im Rajesh R Iyengar Lei Jia Joon Jung Elise Kim Thomas W-H Lee Ara Mermerian Joel Moore Takashi Nakai Nicholas R Perl Jenny Tobin Daniel P Zimmer Paul A Renhowe

Bioorg Med Chem Lett 2021 Mar 1:127886. Epub 2021 Mar 1.

Cyclerion Therapeutics, Inc., 301 Binney Street Cambridge, Massachusetts 02142 United States. Electronic address:

Soluble guanylate cyclase (sGC) is a clinically validated therapeutic target in the treatment of pulmonary hypertension. Modulators of sGC have the potential to treat diseases that are affected by dysregulation of the NO-sGC-cGMP signal transduction pathway. This letter describes the SAR efforts that led to the discovery of CYR715, a novel carboxylic acid-containing sGC stimulator, with an improved metabolic profile relative to our previously described stimulator, IWP-051. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Total Synthesis of Natural Products Containing Enamine or Enol Ether Derivatives.

Authors:
Thomas B Poulsen

Acc Chem Res 2021 Mar 4. Epub 2021 Mar 4.

Department of Chemistry, Aarhus University, Langelandsgade 140, 8000 Aarhus C, Denmark.

ConspectusEnamine and enol ethers are nucleophilic functional groups that are well known to most chemists. When enamine or enol ethers are present in natural products, they are nearly exclusively found as derivatives having a direct connection to electron-withdrawing groups for stabilization, and the resulting larger entities, such as enamides or enol acylates, can be further extended or modified in the framework of natural products. The restricted conformational space that is associated with even simple enamine and enol ether derivatives can be a strong determinant of the overall molecular structure, and the more polarized derivatives can endow some natural products with electrophilic properties and thus facilitate covalent interactions with biological targets. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

LL-37-mediated activation of host receptors is critical for defense against group A streptococcal infection.

Authors:
Debabrata Biswas Poornima Ambalavanan Miriam Ravins Aparna Anand Abhinay Sharma Kimberly Xuan Zhen Lim Rachel Ying Min Tan Hwee Ying Lim Asaf Sol Gilad Bachrach Veronique Angeli Emanuel Hanski

Cell Rep 2021 Mar;34(9):108766

Singapore-HUJ Alliance for Research and Enterprise (SHARE), MMID Phase II, Campus for Research Excellence and Technological Enterprise (CREATE), and Department of Microbiology and Immunology, National University of Singapore, Singapore, Singapore; Department of Microbiology and Molecular Genetics, The Institute for Medical Research, Israel-Canada (IMRIC), The Hebrew University of Jerusalem, Faculty of Medicine, Jerusalem, Israel. Electronic address:

Group A Streptococcus (GAS) causes diverse human diseases, including life-threatening soft-tissue infections. It is accepted that the human antimicrobial peptide LL-37 protects the host by killing GAS. Here, we show that GAS extracellular protease ScpC N-terminally cleaves LL-37 into two fragments of 8 and 29 amino acids, preserving its bactericidal activity. Read More

View Article and Full-Text PDF
March 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap